IMMUNOPRECISE ANTIBODIES LTD (IPA)

CA45257F2008 - Common Stock

0.548  +0.03 (+5.4%)

After market: 0.5256 -0.02 (-4.09%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-10-31)
2024
(2024-4-30)
2023
(2023-4-30)
2022
(2022-4-30)
2021
(2021-4-30)
Revenue
24.07M24.52M20.66M19.36M17.91M
Cost Of Goods
11.97M12.46M9.10M8.38M6.37M
Gross Profit
12.10M12.05M11.56M10.98M11.54M
Operating Expenses
26.60M26.15M40.11M27.23M18.46M
Research and Development
4.72M4.04M12.28M6.69M1.97M
Selling, General, and Administrative Expenses
19.25M19.14M23.42M17.97M13.75M
Operating Income
-14.50M-14.09M-28.55M-16.24M-6.92M
Interest Income/Expense
-771.00K109.00K494.00K487.00K-1.59M
Other Income/Expense
191.00K331.00K332.00KN/AN/A
Non Recurring Items
N/A-15.05M-27.00K-92.00K2.52M
Income Before Taxes
-30.11M-28.70M-27.75M-15.85M-6.00M
Income Tax
-2.58M-1.53M-1.19M861.00K1.34M
Net Income
-27.54M-27.18M-26.56M-16.71M-7.34M
EBITDA
-8.80M-8.36M-21.87M-12.47M-3.21M
 
Per Share Data
EPS Diluted Total Ops
-1.03-1.06-1.07-0.85-0.45
Non GAAP EPS
-0.47-0.46N/AN/AN/A
 
Statistics
Gross Profit Margin
50.27%49.16%55.95%56.72%64.41%
Profit Margin
-114.41%-110.85%-128.53%-86.29%-40.98%
Operating Profit Margin
-60.25%-57.48%-138.16%-83.88%-38.63%

All data in CAD

Charts